Company intelligence / Profile preview

Impiricus

United States

Ownership: Private
Development stage: Commercial

Overview

Impiricus offers an AI-driven communication and engagement platform that connects pharmaceutical companies with healthcare professionals (HCPs) through real-time channels such as SMS, email, and other digital tools. It boasts high engagement rates (98% open rate), rapid campaign deployment (<5 days), and significant ROI for pharma partners. The technology enables compliant, data-driven targeting of hard-to-reach HCPs to improve access to critical resources for patient care.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on Impiricus.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Impiricus.

Explore the full profile